In chronic myeloid leukemia, where the level of expression of the fusion gene BCR-ABL1 is correlated to prognosis, a conversion factor has been established to correct for differences across laboratories. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.